AI: DeepSeek (deepseek-chat)

Q: {
  "guidelineId": "lipid-lowering-therapy-in-pregnancy-pdf",
  "fieldsProcessed": [
    "humanFriendlyName",
    "organisation",
    "yearProduced",
    "summary"
  ],
  "enhancedFields": 4,
  "contentLength": 1773
}

A: {
  "success": true,
  "enhancedFields": [
    {
      "field": "humanFriendlyName",
      "oldValue": null,
      "newValue": "Guideline for Lipid Lowering Therapy in Pregnancy",
      "action": "added"
    },
    {
      "field": "organisation",
      "oldValue": null,
      "newValue": "RCOG",
      "action": "added"
    },
    {
      "field": "yearProduced",
      "oldValue": null,
      "newValue": "I cannot find a publication year in the provided text. The guideline does not include a visible 4-digit year",
      "action": "added"
    },
    {
      "field": "summary",
      "oldValue": null,
      "newValue": "**Summary of Guideline for Using Lipid Lowering Therapy in Pregnancy** - Women with familial hypercholesterolemia should receive specialist care during pregnancy. - Severe hypertriglyceridemia in pregnancy has limited treatment options; fibrates (e.g., fenofibrate) are recommended, especially for pancreatitis or genetic causes. - Omega-3 fish oils (e.g., OMACOR) may be used for hypertriglyceridemia, with caution at high doses. - Icosapent ethyl should be continued if already prescribed; consider initiation in eligible patients. - Statins, ezetimibe, PCSK9 inhibitors, and bile acid sequestrants have varying safety profiles in pregnancyâ€”consult maternal medicine and lipidology specialists. - Bile acid sequestrants are safe during breastfeeding. - Multidisciplinary care is essential for optimal lipid management in pregnancy and breastfeeding",
      "action": "added"
    }
  ]
}